Skip to main content
Clinical Trials/DRKS00015171
DRKS00015171
Recruiting
未知

ovel surgical treatment approaches based on ontogenetic anatomy for vaginal and cervical cancer: TMMR, KMMR, EMMR, LEER and tLNE

niversitätsklinikum Leipzig0 sites600 target enrollmentOctober 29, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
C53
Sponsor
niversitätsklinikum Leipzig
Enrollment
600
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 29, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversitätsklinikum Leipzig

Eligibility Criteria

Inclusion Criteria

  • Patients with histologically proven cervical carcinoma FIGO stages I B to II B or Müllerian vaginal carcinoma FIGO stage I or II without clinical evidence of involvement of the urethrovesical wall.
  • OR: Patients with histologically proven cervical carcinoma FIGO stages IIB / vaginal carcinoma FIGO stage II suspect for urethrovesical wall involvement or cervical carcinoma FIGO stages IIIA, B, IVA / Müllerian vaginal carcinoma FIGO stages III, IVA. In theses cases, the patients must insist on surgical treatment even after consultation with an radio\-oncologist for information about the standard therapy.

Exclusion Criteria

  • Compromised general condition (Karnowsky index \< 80%) or other comorbidity rendering the necessary surgery an inacceptable risk. Physical or psychological inability to cope with the expected sequelae of the operation. Previous pelvic radiation.
  • Previous major pelvic surgery (excluding simple hysterectomy). Advanced tumors infiltrating derivatives of external somatic coelom. Neuroendocrine tumors.

Outcomes

Primary Outcomes

Not specified

Similar Trials